{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:30:13Z","timestamp":1787898613545,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.cger.2006.06.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:08:25Z","timestamp":1168441705000},"page":"735-751","source":"Crossref","is-referenced-by-count":18,"title":["Parkinson's Disease: Background, Diagnosis, and Initial Management"],"prefix":"10.1016","volume":"22","author":[{"given":"Roger L.","family":"Albin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cger.2006.06.003_bib1","series-title":"An essay on the shaking palsy. Whittingham & Rowland for Sherwood, Neely and Jones, 1817","author":"Parkinson","year":"1936"},{"key":"10.1016\/j.cger.2006.06.003_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.cger.2006.06.003_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.cger.2006.06.003_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cger.2006.06.003_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson's disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib6","series-title":"Greenfield's neuropathology","first-page":"699","article-title":"Diseases of the basal ganglia, cerebellum and motor neurons","author":"Oppenheimer","year":"1984"},{"key":"10.1016\/j.cger.2006.06.003_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000215437.80053.d0","article-title":"Practice parameter: diagnosis and prognosis of new onset Parkinson's disease","volume":"66","author":"Suchowersky","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.cger.2006.06.003_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.10333","article-title":"Burden of parkinsonism: a population-based study","volume":"18","author":"Guttman","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2006.06.003_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mds.10619","article-title":"Parkinson's prevalence estimated by a state registry","volume":"19","author":"Strickland","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2006.06.003_bib11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.43.10.1918","article-title":"Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project","volume":"43","author":"Uitti","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.20029","article-title":"Smoking and Parkinson's disease: systemic review of prospective studies","volume":"19","author":"Allam","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2006.06.003_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.281.4.341","article-title":"Parkinson disease in twins: an etiologic study","volume":"281","author":"Tanner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cger.2006.06.003_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.10711","article-title":"Familial aggregation of early- and late-onset Parkinson's disease","volume":"54","author":"Marder","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib15","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJM200012143432404","article-title":"Familial aggregation of Parkinson's disease in Iceland","volume":"343","author":"Sveinbjornsdottir","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cger.2006.06.003_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","article-title":"Genetics of Parkinson's disease","volume":"18","author":"Gasser","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib17","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.cger.2006.06.003_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cger.2006.06.003_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib20","doi-asserted-by":"crossref","first-page":"16535","DOI":"10.1073\/pnas.0508350102","article-title":"Leucine-rich repeat kinase 2: a new player with a familiar theme for Parkinson's disease pathogenesis","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cger.2006.06.003_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.cger.2006.06.003_bib22","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/ana.10488","article-title":"Neuroprotection in Parkinson's disease: clinical trials","volume":"53","author":"Stocchi","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib23","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1002\/ana.410440724","article-title":"DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidate Therapy Of Parkinsonism","volume":"44","author":"Shoulson","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib24","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.50.4.858","article-title":"Levodopa: is toxicity a myth?","volume":"50","author":"Agid","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1212\/01.WNL.0000152880.77812.5B","article-title":"\u201cLevodopa phobia\u201d: a new iatrogenic cause of disability in Parkinson disease","volume":"64","author":"Kurlan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Parkinson Study Group","year":"2004","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.cger.2006.06.003_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.410250509","article-title":"Continuous and intermittent levodopa differentially affect basal ganglia function","volume":"25","author":"Juncos","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cger.2006.06.003_bib28","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease\u2014a randomized controlled trial","volume":"284","author":"Parkinson Study Group","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cger.2006.06.003_bib29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1212\/01.WNL.0000052681.28286.52","article-title":"Initial agonist treatment of Parkinson disease: a critique","volume":"60","author":"Albin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/WNL.58.1.11","article-title":"Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"58","author":"Miyasaki","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/B:JOPA.0000039566.75368.59","article-title":"Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease","volume":"31","author":"Chan","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.cger.2006.06.003_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mds.20325","article-title":"Movement disorder emergencies","volume":"20","author":"Kipps","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.cger.2006.06.003_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.WNL.0000129842.49926.07","article-title":"Pergolide use in Parkinson disease is associated with cardiac valve regurgitation","volume":"63","author":"Baseman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib34","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","article-title":"Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole","volume":"52","author":"Frucht","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.cger.2006.06.003_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069006000346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749069006000346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:28:57Z","timestamp":1547090937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749069006000346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0749069006000346"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2006.06.003","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}